- Home
- APLS vs ATMU Comparison
APLS vs ATMU Comparison
Compare APLS & ATMU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | APLS | ATMU |
|---|---|---|
| Founded | 2009 | 1958 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 5.0B |
| IPO Year | 2015 | 2023 |
Fundamental Metrics
Financial Performance| Metric | APLS | ATMU |
|---|---|---|
| Price | $40.96 | $53.20 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 21 | 4 |
| Target Price | $33.59 | ★ $58.25 |
| AVG Volume (30 Days) | ★ 3.8M | 1.7M |
| Earning Date | 05-04-2026 | 05-01-2026 |
| Dividend Yield | N/A | ★ 0.36% |
| EPS Growth | ★ 112.50 | 12.61 |
| EPS | 0.20 | ★ 0.59 |
| Revenue | $1,003,782,000.00 | ★ $1,764,300,000.00 |
| Revenue This Year | N/A | $15.00 |
| Revenue Next Year | $18.19 | $5.13 |
| P/E Ratio | $204.78 | ★ $85.69 |
| Revenue Growth | ★ 28.46 | 5.67 |
| 52 Week Low | $16.10 | $34.58 |
| 52 Week High | $41.00 | $66.50 |
Technical Indicators
Market Signals| Indicator | APLS | ATMU |
|---|---|---|
| Relative Strength Index (RSI) | 86.68 | 37.87 |
| Support Level | $19.29 | $51.05 |
| Resistance Level | $40.98 | $53.34 |
| Average True Range (ATR) | 0.06 | 2.51 |
| MACD | -0.75 | -1.20 |
| Stochastic Oscillator | 82.50 | 22.66 |
Price Performance
Historical ComparisonAbout APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade. Currently it has two marketed drugs that target C3, the central protein in the complement cascade: SYFOVRE (pegcetacoplan injection) and EMPAVELI (pegcetacoplan).
About ATMU Atmus Filtration Technologies Inc.
Atmus Filtration Technologies Inc manufactures filtration products for on-highway commercial vehicles and off-highway agriculture, construction, mining, and power generation vehicles and equipment. The company designs and manufactures Developed filtration products, principally under the Fleetguard brand, that enable lower emissions and provide asset protection. It designs, manufactures, and sells filters, coolants, and chemical products. The company offers products including air filtration, coolants and chemicals, crankcase ventilation, fuel filtration, fuel cells, lube filtration, and others.